` Comparison: CYCN vs AMGN - Alpha Spread

CYCN
vs
AMGN

Over the past 12 months, CYCN has underperformed AMGN, delivering a return of -45% compared to the AMGN's +24% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CYCN
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CYCN Intrinsic Value
3.98 USD
Undervaluation 67%
Intrinsic Value
Price
AMGN Intrinsic Value
328.67 USD
Overvaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Cyclerion Therapeutics Inc
NASDAQ:CYCN
1.31 USD
Amgen Inc
NASDAQ:AMGN
386.72 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CYCN, AMGN

CYCN
AMGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Cyclerion Therapeutics Inc
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CYCN, AMGN

CYCN
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Cyclerion Therapeutics Inc
NASDAQ:CYCN
Amgen Inc
NASDAQ:AMGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CYCN
0%
AMGN
82.5%

Operating Margin

CYCN
-127.3%
AMGN
44.1%

Net Margin

CYCN
-77%
AMGN
21%

FCF Margin

CYCN
-48.2%
AMGN
22%

ROE

CYCN
-24.8%
AMGN
106.1%

ROA

CYCN
-22.8%
AMGN
8.5%

ROIC

CYCN
-65.5%
AMGN
20.1%

ROCE

CYCN
-41%
AMGN
24.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CYCN, AMGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CYCN, AMGN

Loading
CYCN
AMGN
Difference
www.alphaspread.com

Performance By Year
CYCN, AMGN

Loading
CYCN
AMGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CYCN to other stocks
PNEXF
Pharnext SCA
More expensive
vs CYCN
ABBV
Abbvie Inc
More expensive
vs CYCN
ATXS
Astria Therapeutics Inc
More expensive
vs CYCN
GILD
Gilead Sciences Inc
More expensive
vs CYCN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett